Treatment of neurodegenerative diseases by the use of ATP7A-modulators

Details for Australian Patent Application No. 2004315399 (hide)

Owner CellZome AG

Inventors Ruffner, Heinz; Drewes, Gerard; Hopf, Carsten

Agent Griffith Hack

Pub. Number AU-B-2004315399

PCT Pub. Number WO2005/075632

Priority PCT/ EP2004/004891 07.05.04 EP; 04001895.4 29.01.04 EP

Filing date 29 November 2004

Wipo publication date 18 August 2005

Acceptance publication date 6 August 2009

International Classifications

C12N 9/14 (2006.01) Enzymes, e.g. ligases (6.) - Hydrolases (3.)

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

17 August 2006 PCT application entered the National Phase

  PCT publication WO2005/075632 Priority application(s): WO2005/075632

6 August 2009 Application Accepted

  Published as AU-B-2004315399

3 December 2009 Standard Patent Sealed

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004315404-Porous bodies and method of production thereof

2004315392-Biochip electroporator and its use in multi-site, single-cell electroporation